Forget About the 2026 SpaceX IPO. This Space Stock Is 1500x Cheaper.

LandSpace, a leading private Chinese launch provider, received STAR Market approval to list in early 2026 targeting a roughly $1 billion IPO valuation; the company reported 36.4 million yuan (~$5M) in revenue and losses of $87.6M in H1 2025, with revenue up eightfold year-over-year. Its Zhuque-3 two-stage, stainless-steel reusable launcher (nine first-stage engines, grid fins and legs) reached orbit in December 2025 but failed its landing attempt; LandSpace plans up to 12 launches and ~12 landing attempts in 2026 aiming to achieve rapid reusability progress similar to SpaceX while presenting a lower-cost exposure to commercial launch growth.

Analysis

Market structure: a credible reusable Zhuque-3 shifts pricing power toward low‑cost, high‑cadence launch providers and downstream small-sat OEMs in China. Winners: LandSpace (if it demonstrates reuse), Chinese satellite integrators and stainless‑steel/precision machining suppliers; losers: high‑cost legacy launch providers and incumbents unable to match cadence. If LandSpace hits 6–12 launches in 2026, global small‑sat launch supply could rise ~10–20% versus 2025, pressuring spot launch prices and contract margins over 12–36 months.

Risk assessment: key tail risks are a catastrophic landing failure that stalls investor appetite (could halve IPO valuation), a domestic regulatory clampdown on commercial space or export controls from the U.S. that cut off foreign revenue. Immediate risk window: next 3–6 months (12 planned launches/landing attempts); short term 6–12 months around IPO pricing and first reflies; long term 2–5 years for scale economics. Hidden dependency: meaningful revenue depends on state/PLA or anchor commercial contracts — absence of either lengthens cash‑burn runway materially.

Trade implications: tactical plays favor selective exposure to listed launch/space services (RKLB) and infrastructure beneficiaries (NDAQ for IPO fee flow). Use options to express binary landing/IPO outcomes: buy defined‑risk call spreads ahead of positive catalysts and sell premium into scheduled high‑vol windows. Avoid sizable exposure to LandSpace at IPO until proof of reuse and revenue cadence exist; cap initial exposure at <0.5% until metrics are met.

Contrarian angles: consensus glamorizes a cheap “SpaceX proxy” — overlooked are geopolitical sanctions and slower Chinese domestic demand for repeated launches. Reaction may be overdone on headlines but underdone on regulatory risk; historical parallel: early SpaceX required many loss‑making years before profitable unit economics. Unintended consequence: rapid Chinese reusability progress could trigger export/tech controls that hurt global supply chains and increase idiosyncratic equity volatility.

Key Decisions for Investors

• Establish a 2.5% long position in RKLB (Rocket Lab) within 10 trading days to play secular demand for small/medium launch capacity; hedge tail risk by buying 3‑month 10% OTM puts sized to cap maximum portfolio loss to ~1.5%.
• Buy a defined‑risk RKLB 3‑month call spread (buy 1x 25% OTM call / sell 1x 50% OTM call) sized to 1% portfolio risk to capture positive sentiment from LandSpace/SpaceX catalysts; take profits at +20% absolute or 90 days.
• Do not participate in the LandSpace IPO at listing unless BOTH conditions are satisfied within 90 days post‑IPO: (A) at least one successful first‑stage landing + refly, and (B) IPO market cap ≤ RMB 8 billion (~$1.05B). If either fails, consider a tactical 0.5–1% short via puts on STAR Market peers or an inverse China‑tech ETF within 30 days.
• Initiate a 1–2% long position in NDAQ over the next 3 months to capture IPO fee tailwinds if global space IPO activity accelerates in 2026; set a 12‑month target return of +10–15% and trim on outperformance >25%.